Literature DB >> 8526845

Glial hyaluronate-binding protein: a product of metalloproteinase digestion of versican?

G Perides1, R A Asher, M W Lark, W S Lane, R A Robinson, A Bignami.   

Abstract

Glial hyaluronate-binding protein (GHAP) is a 60 kDa glycoprotein with an amino acid sequence identical to that of the hyaluronate-binding region of versican, a large fibroblast aggregating proteoglycan found in the brain. Both GHAP and versican were identified by immunoblot in bovine brain extracts prepared only minutes after death. Human recombinant collagenase, stromelysin, mouse gelatinase and gelatinases isolated from human brain by affinity chromatography digest versican and give rise to a polypeptide with electrophoretic mobility identical to GHAP. Immunoblot analysis, peptide mapping and C-terminal amino acid sequencing indicate that the polypeptide generated by digestion with human brain gelatinases is identical to GHAP. We suggest that GHAP is a naturally occurring versican degradation product.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8526845      PMCID: PMC1136273          DOI: 10.1042/bj3120377

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

Review 1.  Proteoglycans as modulators of growth factor activities.

Authors:  E Ruoslahti; Y Yamaguchi
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

2.  Purification of recombinant human prostromelysin. Studies on heat activation to give high-Mr and low-Mr active forms, and a comparison of recombinant with natural stromelysin activities.

Authors:  P A Koklitis; G Murphy; C Sutton; S Angal
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

Review 3.  Matrix metalloproteinases and their inhibitors in connective tissue remodeling.

Authors:  J F Woessner
Journal:  FASEB J       Date:  1991-05       Impact factor: 5.191

4.  Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea.

Authors:  M E Fini; M T Girard
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-09       Impact factor: 4.799

5.  Extracellular matrix of central nervous system white matter: demonstration of an hyaluronate-protein complex.

Authors:  R Asher; G Perides; J J Vanderhaeghen; A Bignami
Journal:  J Neurosci Res       Date:  1991-03       Impact factor: 4.164

6.  Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells.

Authors:  G Apodaca; J T Rutka; K Bouhana; M E Berens; J R Giblin; M L Rosenblum; J H McKerrow; M J Banda
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

7.  NGF induction of the gene encoding the protease transin accompanies neuronal differentiation in PC12 cells.

Authors:  C M Machida; K D Rodland; L Matrisian; B E Magun; G Ciment
Journal:  Neuron       Date:  1989-06       Impact factor: 17.173

8.  Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors.

Authors:  T Nakagawa; T Kubota; M Kabuto; K Sato; H Kawano; T Hayakawa; Y Okada
Journal:  J Neurosurg       Date:  1994-07       Impact factor: 5.115

9.  Purification of the neutral proteoglycan-degrading metalloproteinase from human articular cartilage tissue and its identification as stromelysin matrix metalloproteinase-3.

Authors:  Z Gunja-Smith; H Nagase; J F Woessner
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

10.  Multiple domains of the large fibroblast proteoglycan, versican.

Authors:  D R Zimmermann; E Ruoslahti
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

View more
  18 in total

Review 1.  Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment.

Authors:  M D Howell; P E Gottschall
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

2.  Proteolytic cleavage of versican during cardiac cushion morphogenesis.

Authors:  Christine B Kern; Waleed O Twal; Corey H Mjaatvedt; Sarah E Fairey; Bryan P Toole; M Luisa Iruela-Arispe; W Scott Argraves
Journal:  Dev Dyn       Date:  2006-08       Impact factor: 3.780

3.  Versican proteolysis mediates myocardial regression during outflow tract development.

Authors:  Christine B Kern; Russell A Norris; Robert P Thompson; W Scott Argraves; Sarah E Fairey; Leticia Reyes; Stanley Hoffman; Roger R Markwald; Corey H Mjaatvedt
Journal:  Dev Dyn       Date:  2007-03       Impact factor: 3.780

4.  Neuronally produced versican V2 renders C-fiber nociceptors IB4 -positive.

Authors:  Oliver Bogen; Olaf Bender; Jana Löwe; Wolfgang Blenau; Beatrice Thevis; Wolfgang Schröder; Richard U Margolis; Jon D Levine; Ferdinand Hucho
Journal:  J Neurochem       Date:  2015-04-27       Impact factor: 5.372

5.  Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta.

Authors:  S P Evanko; E W Raines; R Ross; L I Gold; T N Wight
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

Review 6.  Applications and emerging trends of hyaluronic acid in tissue engineering, as a dermal filler and in osteoarthritis treatment.

Authors:  A Fakhari; C Berkland
Journal:  Acta Biomater       Date:  2013-03-15       Impact factor: 8.947

7.  Versican: a novel modulator of hepatic fibrosis.

Authors:  Terence N Bukong; Sean B Maurice; Barinder Chahal; David F Schaeffer; Paul J Winwood
Journal:  Lab Invest       Date:  2016-01-11       Impact factor: 5.662

Review 8.  The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis.

Authors:  Sumeda Nandadasa; Simon Foulcer; Suneel S Apte
Journal:  Matrix Biol       Date:  2014-01-18       Impact factor: 11.583

Review 9.  Versican degradation and vascular disease.

Authors:  Richard D Kenagy; Anna H Plaas; Thomas N Wight
Journal:  Trends Cardiovasc Med       Date:  2006-08       Impact factor: 6.677

10.  ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405-Gln406 to generate glial hyaluronate binding protein.

Authors:  Jennifer Westling; Paul E Gottschall; Vivian P Thompson; Amber Cockburn; George Perides; Dieter R Zimmermann; John D Sandy
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.